DCF — UNIVERSITY OF IOWA HOSP & CLINICS
Enterprise Value: $-3.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.0B
Enterprise Value
$-964.9M
PV of Cash Flows
$-2.0B
PV of Terminal Value
$-3.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.3B | $-179.0M | -8.0% | $-277.2M | $-252.0M |
| Year 2 | $2.4B | $-160.5M | -7.0% | $-261.6M | $-216.2M |
| Year 3 | $2.5B | $-140.8M | -6.0% | $-244.9M | $-184.0M |
| Year 4 | $2.5B | $-132.3M | -5.0% | $-239.5M | $-163.6M |
| Year 5 | $2.6B | $-129.8M | -5.0% | $-240.2M | $-149.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08225265624903785
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5